EUCTR2007-003058-26-IT进行中（未招募）不适用
Pilot study on tolerability of specific immunotherapywith injective allergoid adsorbed on calcium phosphate in patients with respiratory allergy to house dust mite. - ND
OFARMA0 个研究点开始时间: 2007年10月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-rhinoconjunctivitis with or without asthma due to allergy to house-dust mite
- •- age: 18-50 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- FEV < 75%
- •- atopic dermatitis or food allergy
- •- patients with previous serious anaphylactic reactions
- •- pregnancy and lactatio
- •- severe systemic diseases
研究者
相似试验
进行中（未招募）
不适用
A trial of antigen-specific immune tolerance induction in mucopolysaccharidosis I (MPS I) patients initiating enzyme replacement therapy with Aldurazyme® (laronidase)EUCTR2007-001163-30-Outside-EU/EEAGenzyme, a Sanofi Company12
进行中（未招募）
1 期
Randomised Study of First Time Immunotolerance Induction in Patients with Severe Type A Haemophilia with Inhibitor at High Risk of Failure: Comparison of Induction of Immune Tolerance with FVIII Concentrates with or without Von Willebrand FactorPatients with severe Haemophilia A with a high responding inhibitor (more than 5 BU/ml)EUCTR2008-007016-15-GBniversity of Milan148
进行中（未招募）
不适用
A Study to Demonstrate Immunogenicity, Tolerability, and Manufacturing Consistency of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered in Preadolescents and Adolescents (9 to 15 year olds), with a Comparison to Young Women (16 to 26 year olds)Cervical CancerEUCTR2009-011617-25-FIMSD Finland Oy2,800
进行中（未招募）
1 期
A Study to Demonstrate Immunogenicity, Tolerability, and Manufacturing Consistency of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered in Preadolescents and Adolescents (9 to 15 year olds), with a Comparison to Young Women (16 to 26 year olds)MedDRA version: 12.0Level: LLTClassification code 10063001Term: Human papilloma virus infectionCervical CancerEUCTR2009-011617-25-ATMerck & Co., Inc.2,800
招募中
不适用
A pilot study to investigate the immunological regulation of preeclampsiaO14Pre-eclampsiaDRKS00025864Carl von Ossietzky Universität Oldenburg/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe200